FDA drug class
Endoglycosidases list
Every FDA-approved prescription drug the FDA NDC directory tags with the Endoglycosidase [EPC] class, with brand names and DEA schedules.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
The FDA NDC directory lists 2 single-ingredient drugs in this class: hyaluronidase, hyaluronidase (human recombinant). Another 10 combination products include one of them.
Run it in Rivvi
Map Amphadase and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Endoglycosidases (12)
| Drug | Brand names | Type | NDC listings | DEA schedule |
|---|---|---|---|---|
| Hyaluronidase | Amphadase | Single ingredient | 1 | Not controlled |
| Hyaluronidase (human recombinant) | HYLENEX Recombinant | Single ingredient | 2 | Not controlled |
| Amivantamab and hyaluronidase (human recombinant) | Rybrevant Faspro | Combination | 4 | Not controlled |
| Atezolizumab and hyaluronidase (human recombinant) | Tecentriq Hybreza | Combination | 1 | Not controlled |
| Daratumumab and hyaluronidase (human recombinant) | Darzalex Faspro | Combination | 1 | Not controlled |
| Efgartigimod alfa and hyaluronidase (human recombinant) | VYVGART Hytrulo | Combination | 2 | Not controlled |
| Nivolumab and hyaluronidase (human recombinant) | Opdivo Qvantig | Combination | 2 | Not controlled |
| Ocrelizumab and hyaluronidase (human recombinant) | Ocrevus Zunovo | Combination | 1 | Not controlled |
| Pembrolizumab and berahyaluronidase alfa | Keytruda Qlex | Combination | 2 | Not controlled |
| Pertuzumab, trastuzumab and hyaluronidase (human recombinant) | Phesgo | Combination | 2 | Not controlled |
| Rituximab and hyaluronidase (human recombinant) | Rituxan Hycela | Combination | 2 | Not controlled |
| Trastuzumab and hyaluronidase (human recombinant) | Herceptin Hylecta | Combination | 1 | Not controlled |
FDA established pharmacologic class: Endoglycosidase [EPC].
Questions
What drugs are Endoglycosidases?
The FDA NDC directory lists 2 single-ingredient drugs in this class: hyaluronidase, hyaluronidase (human recombinant). Another 10 combination products include one of them.
Where does this list come from?
From the established pharmacologic class (EPC) field FDA publishes for each listing in the NDC directory. A drug is listed when most of its prescription listings carry the class.